Pediatric Graves’ disease in Argentina: analyzing treatment strategies and outcomes
ATD, our first line treatment, resulted in low remission rates for Hispanic pediatric patients with severe thyrotoxicosis at diagnosis. Poor adherence issues contributed to the indication of DT (46 %) and loss to follow-up (31 %) during the studied period. Based on our findings, DT should be considered at 4 years of ATD in persisting PGD.
Authors
- Patricia Papendieck
- Ana Chiesa (ORCID: https://orcid.org/0000-0003-3123-4523)
- Anna Rothenfusser
Institutions
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Hospital General de Niños Ricardo Gutierrez (AR)
Publication Details
- Journal
- Journal of Pediatric Endocrinology and Metabolism
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1515/jpem-2024-0394
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00